Randomised Controlled TrialtaVNSn = 45

Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA

Gierthmuehlen M, Schmieder K, Thon N, Gierthmuehlen PC

Neurology and Therapy · 2026

Key finding

In 45 patients randomized to sham, sub-threshold or above-threshold taVNS for 4 weeks, taVNS was safe and well-tolerated but showed no superiority over sham stimulation for long COVID fatigue.

Condition
Long COVID
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
45
View on DOI

Cite this study

Gierthmuehlen, M., Schmieder, K., Thon, N., & Gierthmuehlen, P. C. (2026). Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA. Neurology and Therapy, 15(3), 1327-1343. https://doi.org/10.1007/s40120-026-00928-w

Related studies in Long COVID

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.